164 related articles for article (PubMed ID: 15629368)
1. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
[TBL] [Abstract][Full Text] [Related]
6. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
7. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
8. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
10. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
[TBL] [Abstract][Full Text] [Related]
11. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
Hernández-Romero D; Marín F; Lee KW; Roldán V; Caturla J; Corral J; Valdés M; Lip GY; Vicente V; González-Conejero R
Thromb Haemost; 2010 Sep; 104(3):650-2. PubMed ID: 20589311
[No Abstract] [Full Text] [Related]
12. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
[TBL] [Abstract][Full Text] [Related]
13. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
[TBL] [Abstract][Full Text] [Related]
14. Association of a common polymorphism in the factor XIII gene with myocardial infarction.
Kohler HP; Stickland MH; Ossei-Gerning N; Carter A; Mikkola H; Grant PJ
Thromb Haemost; 1998 Jan; 79(1):8-13. PubMed ID: 9459313
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
[TBL] [Abstract][Full Text] [Related]
16. FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct.
Akar N; Dönmez B; Deda G
J Child Neurol; 2007 Feb; 22(2):222-4. PubMed ID: 17621488
[TBL] [Abstract][Full Text] [Related]
17. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
Bagheri M; Rad IA; Omrani MD; Nanbaksh F
Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
[TBL] [Abstract][Full Text] [Related]
18. Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus.
de Lange M; Andrew T; Snieder H; Ge D; Futers TS; Standeven K; Spector TD; Grant PJ; Ariëns RA
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1914-9. PubMed ID: 16763156
[TBL] [Abstract][Full Text] [Related]
19. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
[TBL] [Abstract][Full Text] [Related]
20. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.
Bronić A; Ferencak G; Zadro R; Stavljenić-Rukavina A; Bernat R
Mol Biol Rep; 2009 Jan; 36(1):1-5. PubMed ID: 17899444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]